Albert Z. Luu

1. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension
   2020/01/21 by Biswajit Chowdhury, Albert Z. Luu, Vincent Z. Luu +12 · 26 citations
   Medicine · #Pulmonary Hypertension Research and Treatments #Heart Failure Treatment and Management #Peptidase Inhibition and Analysis